Your browser doesn't support javascript.
loading
Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trial.
Wang, Leiping; Cao, Jun; Li, Chunlei; Wang, Xiaodong; Zhao, Yannan; Li, Ting; Du, Yiqun; Tao, Zhonghua; Peng, Wenxia; Wang, Biyun; Zhang, Jian; Zhang, Sheng; Wang, Zhonghua; Hu, Xichun.
Affiliation
  • Wang L; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Cao J; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Li C; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Wang X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhao Y; Department of Medicine, CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd, Shanghai, China.
  • Li T; Department of Medicine, CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd, Shanghai, China.
  • Du Y; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Tao Z; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Peng W; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Wang B; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang J; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zhang S; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Wang Z; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Hu X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Invest New Drugs ; 40(2): 330-339, 2022 04.
Article in En | MEDLINE | ID: mdl-34633576

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Mitoxantrone Type of study: Clinical_trials Limits: Female / Humans Country/Region as subject: Asia Language: En Journal: Invest New Drugs Year: 2022 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Mitoxantrone Type of study: Clinical_trials Limits: Female / Humans Country/Region as subject: Asia Language: En Journal: Invest New Drugs Year: 2022 Type: Article Affiliation country: China